Cargando…

Correspondence on 'Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016' by Sussman et al

Detalles Bibliográficos
Autores principales:	Grant, Christopher, Hagopian, Garo, Tran, Thuy B, Nagaraj, Gayathri, Moyers, Justin T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743369/ https://www.ncbi.nlm.nih.gov/pubmed/36600605 http://dx.doi.org/10.1136/jitc-2022-006187

Ejemplares similares

Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
por: Sussman, Tamara A, et al.
Publicado: (2022)

Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US
por: Moyers, Justin T., et al.
Publicado: (2020)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
por: Moyers, Justin T., et al.
Publicado: (2021)

NCDB Analysis of Melanoma 2004–2015: Epidemiology and Outcomes by Subtype, Sociodemographic Factors Impacting Clinical Presentation, and Real-World Survival Benefit of Immunotherapy Approval
por: Singh, Sunny R. K., et al.
Publicado: (2021)

Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

Odds of Stage IV Bone Cancer Diagnosis Based on Socioeconomic and Geographical Factors: A National Cancer Database (NCDB) Review
por: McMahon, Kevin M, et al.
Publicado: (2023)

Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy
por: Kaakour, Dalia, et al.
Publicado: (2022)

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
por: Hirsh, Vera, et al.
Publicado: (2017)

ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

The Use of Radiation Therapy in Well-Differentiated Soft Tissue Sarcoma of the Extremities: An NCDB Review
por: Lazarides, Alexander L., et al.
Publicado: (2015)

Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: an NCDB analysis
por: Zhu, Liling, et al.
Publicado: (2019)

Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB
por: WJ, Hotsinpiller, et al.
Publicado: (2021)

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis
por: Chen, Kai, et al.
Publicado: (2015)

Exploring trends in advanced bladder cancer using the NCDB: turning data into information and information into insight
por: Thiruthaneeswaran, Niluja, et al.
Publicado: (2018)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

A case report: metastasis of melanoma to the heart in an era of immunotherapy
por: Poulsen, Christian B, et al.
Publicado: (2019)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy
por: Blankenstein, Stephanie A., et al.
Publicado: (2020)

The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis
por: Huang, Binhao, et al.
Publicado: (2021)

Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis
por: Reif de Paula, Thais, et al.
Publicado: (2021)

Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study
por: Gupta, Ashish, et al.
Publicado: (2023)

Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes
por: Gonçalves, Lisa, et al.
Publicado: (2023)

Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
por: Sahni, Sakshi, et al.
Publicado: (2018)

Abstract QS2: Influence of Race, Income, Insurance and Education in Rate of Breast Reconstruction: an NCDB 2004–15 Analysis
por: Restrepo, David J., et al.
Publicado: (2019)

Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis
por: Bilani, Nadeem, et al.
Publicado: (2020)

Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
por: Rodriguez, Robin R., et al.
Publicado: (2021)

Chondrosarcoma patient characteristics, management, and outcomes based on over 5,000 cases from the National Cancer Database (NCDB)
por: Ottesen, Taylor D., et al.
Publicado: (2022)

Changes in healthcare costs and survival in the era of immunotherapy and targeted systemic therapy for melanoma.
por: Nguyen, Paul, et al.
Publicado: (2022)

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
por: Parsons, Benjamin M., et al.
Publicado: (2016)

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
por: Stafford, Arielle, et al.
Publicado: (2020)

Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

Israel Seminar 2014-2016
por: Klartag, Bo'az, et al.
Publicado: (2017)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
por: Yusuf, Mehran, et al.
Publicado: (2021)

Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
por: Stevenson, Valentina B., et al.
Publicado: (2023)

The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis
por: Liu, Jieqiong, et al.
Publicado: (2015)

Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB)
por: Mukhtar, Rita A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62i83t3rnba31f9btn8ei42ni5